Epstein-Barr virus and multiple sclerosis: lesson learned to develop better nonhuman primate models

Area of Science:

• Neuroimmunology
• Virology
• Translational Medicine

Background:

• Multiple sclerosis (MS) is a chronic autoimmune disease with a complex cause, where Epstein-Barr virus (EBV) is a primary suspect.
• Understanding EBV's role in MS pathogenesis is vital, but human studies are limited.
• Nonhuman primate (NHP) models offer a controlled environment to test EBV-MS hypotheses and identify therapeutic targets.

Purpose of the Study:

• To address clinically relevant questions about the EBV-MS connection.
• To inform the development and refinement of EBV-induced NHP models for MS research.
• To integrate known EBV-related risk factors into NHP model design.

Main Methods:

• Review of existing literature on EBV infection and MS.
• Analysis of EBV-related risk factors: age at infection, infectious mononucleosis, HLA-DR15, sex, vitamin D, and CD8+ T cell deficiency.
• Proposal for developing a refined EBV infection NHP model of MS with CD8+ cell depletion.

Main Results:

• Identified key EBV-related risk factors for MS.
• Explored the application of these risk factors in NHP model development.
• Investigated reasons why most EBV-infected individuals do not develop MS.
• Proposed potential disease-modifying therapies and vaccines.

Conclusions:

• Integrating EBV risk factors into NHP models will enhance understanding of MS pathogenesis.
• Refined NHP models are crucial for guiding targeted strategies in MS management and prevention.
• A proposed NHP model incorporating EBV infection and CD8+ cell depletion could advance MS research.